HST Global (HSTC) Stock Price, News & Analysis

Company Overview

HST Global, Inc. is a healthcare and biotechnology company focused on alternative and complementary approaches to cancer care. Its activities have included the development and promotion of non-toxic treatment protocols intended to support patients undergoing cancer treatment.

The company has also been associated with wellness services and nutritional products designed to complement its therapeutic programs. Publicly available information about HST Global’s current operations, geographic reach, and leadership is limited.

Key Stats

• Today's Range: $0.07 to $0.70
• 50-Day Range: $0.07 to $0.70
• 52-Week Range: $0.01 to $1.05
• Volume: 783 shs
• Average Volume: 101 shs
• Market Capitalization: $14.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/20/2017
• Today: 10/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:HSTC
• CIK: 797564
• Web: www.hstglobal.com
• Phone: (757) 766-6100
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$860 thousand
• Net Margins: -61.47%
• Pretax Margin: -61.50%
• Return on Equity: -3.64%
• Return on Assets: -3.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.78
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: $520 thousand
• Price / Sales: 27.20
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.18 per share
• Price / Book: 0.56

Miscellaneous

• Outstanding Shares: 141,430,000
• Free Float: 48,341,000
• Market Cap: $14.14 million
• Optionable: Not Optionable
• Beta: -390.24